Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2017
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
52,316
-47.03%
|
$4,289,912
$82.33 P/Share
|
|
Mar 02
2017
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
52,316
+14.2%
|
$3,243,592
$62.76 P/Share
|
|
Mar 02
2017
|
Randall J Hogan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,109
+31.76%
|
$407,943
$27.38 P/Share
|
|
Mar 01
2017
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,974
-21.19%
|
$571,868
$82.07 P/Share
|
|
Mar 01
2017
|
Craig Arnold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,109
+31.46%
|
$407,943
$27.38 P/Share
|
|
Feb 17
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,751
-1.17%
|
$136,578
$78.88 P/Share
|
|
Jan 05
2017
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,387
+3.75%
|
$182,898
$54.14 P/Share
|
|
Dec 30
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Bona fide gift
|
Direct |
10,000
-5.24%
|
-
|
|
Dec 13
2016
|
Robert C Pozen Director |
BUY
Open market or private purchase
|
Direct |
13,660
+16.89%
|
$997,180
$73.21 P/Share
|
|
Dec 01
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,155
-2.7%
|
$295,005
$71.88 P/Share
|
|
Nov 23
2016
|
James T Lenehan Director |
BUY
Open market or private purchase
|
Direct |
2,000
+4.73%
|
$146,000
$73.27 P/Share
|
|
Oct 28
2016
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,618
-18.3%
|
$1,022,058
$81.93 P/Share
|
|
Sep 27
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
17,141
-13.8%
|
$1,474,126
$86.7 P/Share
|
|
Sep 26
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
25,199
-16.86%
|
$2,167,114
$86.67 P/Share
|
|
Sep 26
2016
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
30,624
+17.01%
|
$1,071,840
$35.92 P/Share
|
|
Sep 15
2016
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
61,925
-9.86%
|
$5,201,700
$84.93 P/Share
|
|
Sep 15
2016
|
Kendall J Powell Director |
SELL
Open market or private sale
|
Direct |
7,907
-23.06%
|
$672,095
$85.44 P/Share
|
|
Sep 15
2016
|
Kendall J Powell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,061
+6.2%
|
$452,745
$45.78 P/Share
|
|
Aug 29
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
15,000
-8.92%
|
$1,305,000
$87.0 P/Share
|
|
Aug 29
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.19%
|
$435,000
$29.52 P/Share
|
|
Aug 16
2016
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,493
+2.77%
|
$68,678
$46.91 P/Share
|
|
Aug 01
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
BUY
Grant, award, or other acquisition
|
Direct |
16,561
+8.01%
|
-
|
|
Aug 01
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
20,063
+18.16%
|
-
|
|
Aug 01
2016
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
20,441
+16.26%
|
-
|
|
Aug 01
2016
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,328
+10.85%
|
-
|
|
Aug 01
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Grant, award, or other acquisition
|
Direct |
59,241
+17.12%
|
-
|
|
Aug 01
2016
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,356
+15.11%
|
-
|
|
Aug 01
2016
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
51,102
+7.53%
|
-
|
|
Aug 01
2016
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,063
+20.51%
|
-
|
|
Aug 01
2016
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
60,944
+18.61%
|
-
|
|
Aug 01
2016
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
11,356
+17.9%
|
-
|
|
Aug 01
2016
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
9,842
+7.65%
|
-
|
|
Jul 29
2016
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
5,410
-6.02%
|
$470,670
$87.63 P/Share
|
|
Jul 29
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Payment of exercise price or tax liability
|
Direct |
7,686
-4.24%
|
$668,682
$87.63 P/Share
|
|
Jul 29
2016
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
28,294
-4.68%
|
$2,461,578
$87.63 P/Share
|
|
Jul 29
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,918
-4.32%
|
$427,866
$87.63 P/Share
|
|
Jul 29
2016
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,821
-6.9%
|
$158,427
$87.63 P/Share
|
|
Jul 29
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
245
-0.79%
|
$21,315
$87.63 P/Share
|
|
Jul 28
2016
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
7,636
-15.79%
|
$664,332
$87.42 P/Share
|
|
Jul 26
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
15,000
-13.8%
|
$1,305,000
$87.0 P/Share
|
|
Jul 26
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+12.12%
|
$435,000
$29.52 P/Share
|
|
Jul 15
2016
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
3,766
-12.54%
|
$331,408
$88.26 P/Share
|
|
Jul 13
2016
|
Shirley A Jackson Director |
SELL
Open market or private sale
|
Direct |
2,104
-5.83%
|
$185,152
$88.64 P/Share
|
|
Jul 13
2016
|
Shirley A Jackson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+3.53%
|
$132,600
$51.59 P/Share
|
|
Jul 13
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Open market or private sale
|
Direct |
35,495
-16.4%
|
$3,123,560
$88.64 P/Share
|
|
Jul 13
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
BUY
Exercise of conversion of derivative security
|
Direct |
41,068
+15.95%
|
$1,971,264
$48.7 P/Share
|
|
Jul 06
2016
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
9,787
-14.07%
|
$851,469
$87.08 P/Share
|
|
Jul 05
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
15,272
-14.01%
|
$1,328,664
$87.11 P/Share
|
|
Jul 05
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Exercise of conversion of derivative security
|
Direct |
15,272
+12.29%
|
$412,344
$27.29 P/Share
|
|
Jun 24
2016
|
Richard H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,577
+2.74%
|
$377,388
$44.84 P/Share
|